Insmed reported $3.52B in Market Capitalization for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Acelrx Pharmaceuticals ACRX:US $ 202.21M 79.69M
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
Alimera Sciences ALIM:US $ 55.35M 31.21M
Arena Pharmaceuticals ARNA:US $ 4.2B 264.09M
Biomarin Pharmaceutical BMRN:US $ 13.79B 2.12B
Cytokinetics CYTK:US $ 1.66B 193.15M
Dynavax Technologies DVAX:US $ 1.11B 623.04M
Flexion Therapeutics FLXN:US $ 446.82M 122.28M
Gilead Sciences GILD:US $ 81.37B 8.34B
Heron Therapeutics HRTX:US $ 1.48B 441.41M
Insmed INSM:US $ 3.52B 96.4M
Mirati Therapeutics MRTX:US $ 8.79B 2.25B
Novartis NVS:US 224.91B 13.69B
Ophthotech OPHT:US $ 557.25M 61.66M
Regeneron Pharmaceuticals REGN:US $ 50.69B 862.48M
Sarepta Therapeutics SRPT:US $ 5.92B 7.53B
Seattle Genetics SGEN:US $ 25.18B 6.4B
Ultragenyx Pharmaceutical RARE:US $ 7.62B 1.5B
Vertex Pharmaceuticals VRTX:US $ 55.62B 5.84B